Clinical course of HTLV-1 infection associated intermediate uveitis.

Objective: To describe the clinical features at presentation, delivered treatment and follow-up of a case series of human T-cell lymphotropic virus type 1 (HTLV-1) associated intermediate uveitis.

Patients And Methods: Retrospective, descriptive and longitudinal study of patients with HTLV-1 associated intermediate uveitis treated at a reference ophthalmology facility in Lima, Peru, during the years 2012 to 2018.

Results: A total of 18 patients (28 eyes) were included, the average age at presentation was 57.